Phio Pharmaceuticals Corp (PHIO) Aandeelprys en nuus – Google Finansies

TuisPHIO • NASDAQ

Phio Pharmaceuticals Corp

$2,70

Na ure:

$2,70

(0,00%)0,00

Toe: 16 Apr., 16:05:31 GMT-4 · USD · NASDAQ · Vrywaring

AandeelVSA-gelyste effekHoofkantoor in VSA

Vorige sluiting

$2,43

Dagwisseling

$2,35 - $2,94

Jaarwisseling

$0,97 - $9,79

Markkapitalisasie

12,90 m USD

Gemiddelde volume

5,65 m

P/V-verhouding

-

Dividend-opbrengs

-

Primêre beurs

NASDAQ

Marknuus

49 minute gelede

Stock market today: Dow, S&P 500, Nasdaq smoked as Powell warns of 'challenging' tariff impact, Nvidia plunges

Investor's Business Daily

Fed Chief Jerome Powell Signals Trump Tariffs 'Tension' On Inflation, Growth; Dow Jones Extends Losses

Wall Street’s 12 favorite stocks could soar as much as 54% over the next year, analysts say

Wall St tumbles, Nvidia drops after new US chip export curbs

Stocks Post Gains; Dow Rises More Than 300 Points

5 EYEWITNESS NEWS

9 minute gelede

S&P 500 falls 3% as losses accelerate with Nvidia and other tech stocks leading the way lower

Meer oor

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia

Gestig

2011

Hoofkwartier

Marlborough, Massachusetts
Verenigde State van Amerika

Webwerf

Werknemers

5

Search

Vee soektog uit

Maak soekkassie toe

Google-programme

Hoofkieslys